Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nicardipine infusion for intraoperative hypertension control in three dogs undergoing adrenalectomy for pheochromocytoma.

Veterinary anaesthesia and analgesia·2026

Same author

Awareness, importance and performance of sustainable diets among university students in Daegu and Gyeongbuk, Korea: a cross-sectional study.

Korean journal of community nutrition·2026

Same author

Utility of intraoperative 3-dimensional C-arm cone-beam computed tomography for hepatic transarterial chemoembolization.

Frontiers in veterinary science·2026

Same author

A β‑1,3‑1,6‑glucan from <i>Aureobasidium pullulans</i> enhances apoptotic and autophagic pathways in colorectal cancer cells.

Molecular medicine reports·2026

Same author

Leverage of quick-soluble gelatin microparticles in transarterial chemoembolization of canine urothelial carcinomas.

The veterinary quarterly·2026

Same author

Recurrent pyuria is associated with shorter progression-free survival in dogs with bladder urothelial carcinoma.

American journal of veterinary research·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Indirubin derivative E804 inhibits angiogenesis.

Eun-Kyung Shin¹, Jin-Kyung Kim

¹Center for Efficacy Assessment and Development of Functional Foods andDrugs, Hallym University, Chuncheon, Republic of Korea.

|May 5, 2012

Summary

Indirubin derivative E804 (IDR-E804) effectively inhibits angiogenesis by reducing endothelial cell proliferation, migration, and tube formation. This compound also demonstrates anti-tumor efficacy by suppressing tumor growth and vascularization in vivo.

More Related Videos

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

Area of Science:

Oncology
Molecular Biology
Cell Biology

Background:

Indirubin derivative E804 (IDR-E804) previously shown to inhibit STAT-3 signaling and Src kinase.
IDR-E804's role in angiogenesis requires further investigation.

Purpose of the Study:

To evaluate the anti-angiogenic potential of IDR-E804 using human umbilical vein endothelial cells (HUVECs).
To analyze the effects of IDR-E804 on cellular and molecular events critical for angiogenesis.
To assess the in vivo efficacy of IDR-E804 in inhibiting tumor growth.

Main Methods:

Assessed HUVEC proliferation, migration, and capillary tube formation induced by vascular endothelial growth factor (VEGF) with varying IDR-E804 concentrations.
Investigated IDR-E804's effect on angiogenesis and tumor growth in a mouse model (CT-26 colon cancer cells).

Main Results:

IDR-E804 significantly reduced VEGF-induced HUVEC proliferation, migration, and tube formation.
Observed decreased phosphorylation of VEGFR-2, AKT, and ERK in HUVECs treated with IDR-E804.
IDR-E804 treatment led to reduced tumor growth, decreased microvessel density (CD31), and proliferation (Ki-67), with increased apoptosis in tumors.

Conclusions:

IDR-E804 acts as a potent inhibitor of angiogenesis.
IDR-E804 shows promise as an effective anti-tumor therapeutic agent.